Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 30, 2024

BUY
$20.78 - $31.77 $4,862 - $7,434
234 New
234 $7,000
Q1 2020

May 06, 2020

SELL
$31.65 - $46.87 $2,437 - $3,608
-77 Closed
0 $0
Q4 2019

Feb 05, 2020

SELL
$36.21 - $51.4 $1,882 - $2,672
-52 Reduced 40.31%
77 $3,000
Q3 2019

Nov 04, 2019

BUY
$22.22 - $44.01 $2,866 - $5,677
129 New
129 $5,000

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $3.24B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Macroview Investment Management LLC Portfolio

Follow Macroview Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macroview Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Macroview Investment Management LLC with notifications on news.